Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
InChiKey: NMVMURBPQFKTAX-UHFFFAOYSA-N
0000000000002660
InChiKey: QQDGMPOYFGNLMT-UHFFFAOYSA-N
Smiles: OCCOCCOCCOCCCCCCCCCCCS
the retention of several DNA damage response proteins in foci that form around DSBs
6-Hydroxyazepan-2-one alacic acid InChiKey: NMVMURBPQFKTAX-UHFFFAOYSA-NIsavuconazole (BAL4815; trade name Cresemba) is a triazole antifungal drug. Its prodrug, isavuconazonium sulfate (BAL8557), was granted approval by the U. S. Food and Drug Administration (FDA) on March 6, 2015. Isavuconazole has been approved for treatment of invasive aspergillosis and invasive mucormycosis in adults ages 18 years and older. Both infections are caused by mold and fungi common to the environment, and occur in individuals who are